This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Trabeculectomy with MMC in post-traumatic angle recession glaucoma

Trabeculectomy with MMC in post-traumatic angle recession glaucoma
Reviewed by Su Young

1 June 2022 | Su Young | EYE - Glaucoma | angle recession, blunt injury, fellow eye, mitomycin-c, trabeculectomy
Share This

This study aimed to evaluate the outcomes of primary trabeculectomy with mitomycin-C (trab MMC) in phakic eyes with post-traumatic angle recession glaucoma with no prior intraocular surgery. Thirty-two phakic eyes of 32 patients who underwent trab MMC between January-2002 and December-2017 were included. Complete success was defined as IOP between 6- and 21mmHg without anti-glaucoma medications (AGM) and failure was with IOP >21mmHg with AGM or need for additional intervention for IOP control or loss of light perception. Subjects had a mean age (± standard deviation) of 30.6 ±12.6 years. The majority were male (97.6%), the major cause of blunt trauma was sports injury in 28/32 eyes (88%) and 24/32 eyes (75%) had >180-degree angle recession. The median (interquartile range) follow-up duration was 1.3 years (0.3,3.5). There was significant IOP reduction at one-year postoperatively (34 (28,40) to 13 (12,16) mmHg; p < 0.001). The median postoperative AGM at one-year was significantly less (4 (3,4) to 0; p < 0.001) with stable logMAR visual acuity (p = 0.24). The complete survival of trab MMC was 88% at one year and was 77% from two to five years. Complications were intraoperative vitreous prolapse needing limited vitrectomy in two eyes and postoperative choroidal detachment in two eyes that resolved with conservative management. The contralateral eyes of three patients (9.7%) developed elevated IOP during the follow-up period. The authors hypothesise this may be secondary to several factors, such as an underlying predisposition to glaucoma and missed pre-existing glaucoma. The authors conclude that trabeculectomy with mitomycin-C in phakic eyes with traumatic angle recession glaucoma had good safety and efficacy in the medium-term follow-up, however, follow up is warranted for the fellow eye.

Trabeculectomy with mitomycin-C in post-traumatic angle recession glaucoma in phakic eyes with no prior intraocular intervention.
Senthil S, Dangeti D, Battula M, et al.
SEMINARS IN OPHTHALMOLOGY
2022;37:(2):171-6.
Share This
Su Young
CONTRIBUTOR
Su Young

Tennent Institute of Ophthalmology, NHS Greater Glasgow and Clyde, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency